Clinical trials: Gastric Retention

Gastric Retention, Healthy

Study Determining Gastric-Retentive and Modified Release Properties of Prototype Capsules in Healthy Subjects

• Terminated
• Age: 18 to 60 years
• Early Phase 1
• Pill or oral medicine
• Results posted

To assess how long modified release (MR) memantine hydrochloride prototype capsule formulations stay in the stomach as determined by magnetic resonance imaging (MRI).

Trial name

NCT03468543

Testing

Memantine Hydrochloride MR Prototype Capsule Formulation A, Memantine Hydrochloride MR Prototype Capsule Formulation B, Memantine Hydrochloride MR Prototype Capsule Formulation C

Where

United Kingdom

Volunteers

3 people, healthy volunteers welcome

Sponsor

Lyndra Inc.